PharmaShots | Incisive News in 3 Shots

Subscribe Now

Menarini

Menarini Entered into an Exclusive License Agreement with Astellas to Commercialize Smyraf in Taiwan and Selected South-East Asian markets

Menarini Entered into an Exclusive License Agreement with Astellas to Commercialize Smyraf in Taiwan and Selected South-East Asian...

September 14, 2023

Menarini Reports EMA's Validation of MAA for Elacestrant to Treat ER+/HER2- Advanced or Metastatic Breast Cancer

Menarini Reports EMA's Validation of MAA for Elacestrant to Treat ER+/HER2- Advanced or Metastatic Breast Cancer

August 19, 2022

Glenmark's Ryaltris Nasal Spray Receives EC's Approval as 1L Treatment for Allergic Rhinitis

Glenmark's Ryaltris Nasal Spray Receives EC's Approval as 1L Treatment for Allergic Rhinitis

April 27, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us